Trial Profile
Mometasone/formoterol (200/10 or 400/10 microg/dose) vs salmeterol/fluticasone propionate in patients with mild-to-moderate asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Mometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 04 Feb 2013 New trial record